Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety, Efficacy and Persistence of Advanced Therapies in Inflammatory Bowel Disease: Results from ORIGINS. A Retrospective Observational Study.
Mateescu RB, Gheorghe C, Trifan AV, Saftoiu A, Seicean A, Diculescu MM, Banciu C, Gheorghe LS, Busuioc B, Goldis A, Dobru D, Fratila O, Eugen D, Bataga S, Constantinescu G, Gheonea D, Tantau A, Jinga M, Brisc C, Cijevschi Prelipcean C, Chira R, Fierbințeanu-Braticevici C, Dumitrascu D, State M, Voiosu T, Negreanu L. Mateescu RB, et al. Among authors: gheorghe ls. J Gastrointestin Liver Dis. 2023 Dec 22;32(4):444-451. doi: 10.15403/jgld-5128. J Gastrointestin Liver Dis. 2023. PMID: 38147607 Free article.
Efficacy and Safety of Ledispavir/Sofosbuvir with or without Ribavirin in patients with Decompensated Liver Cirrhosis and Hepatitis C Infection: a Cohort Study.
Gheorghe LS, Preda C, Iliescu L, Istratescu D, Chifulescu AE, Pop CS, Trifan A, Stanciu C, Diculescu M, Voiosu T, Baicus C, Tugui L, Iacob S, Tieranu C, Meianu C, Manuc M. Gheorghe LS, et al. J Gastrointestin Liver Dis. 2020 Sep 9;29(3):385-390. doi: 10.15403/jgld-2448. J Gastrointestin Liver Dis. 2020. PMID: 32919421 Free article.
Occurrence and recurrence of hepatocellular carcinoma in patients with HCV genotype 1b related cirrhosis treated with Ledipasvir + Sofosbuvir ± Ribavirin.
Pop CS, Preda CM, Manuc M, Gheorghe LS, Istratescu D, Chifulescu AE, Voiosu T, Diculescu M, Tieranu C, Iliescu L. Pop CS, et al. Among authors: gheorghe ls. J Gastrointestin Liver Dis. 2020 Dec 13;29(4):690-691. doi: 10.15403/jgld-3148. J Gastrointestin Liver Dis. 2020. PMID: 33331348 Free article. No abstract available.
Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST Study.
Trifan A, Stanciu C, Iliescu L, Sporea I, Baroiu L, Diculescu M, Luca MC, Miftode E, Cijevschi C, Mihai C, Sparchez ZA, Pojoga C, Streinu-Cercel A, Gheorghe L. Trifan A, et al. J Gastrointestin Liver Dis. 2021 Mar 13;30(1):88-93. doi: 10.15403/jgld-3373. J Gastrointestin Liver Dis. 2021. PMID: 33723561 Free article.
39 results